![](https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)
Pharmaceutical Regulatory Processes in Switzerland
By pharma services oehler
This white paper highlights what it takes to bring a drug to the Swiss market, including the marketing authorisation application MAA), preapproval and launch preparation milestones and covering topics such as regulatory affairs, market access, quality management and pharmacovigilance.
![](https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)